National feature spotlights TumorSight™ Viz’s clinical use at Mercy Cedar Rapids and initiative with NVIDIA advancing AI-powered precision breast cancer care CHICAGO, IL – October 27, 2025 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and…
By Stacey Stevens, President & CEO, SimBioSys Every October, pink ribbons remind us of how far we’ve come in the fight against breast cancer — and how far we still have to go. Despite remarkable progress in awareness, screening, and…
